Acquiring Company
GSK
Acquired Company
Pfizer
London
New YorkManufacturingBiotechnologyHealth CareBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharmapharmaceuticalsDescription
In 2019, GSK and Pfizer combined their consumer healthcare businesses, aiming for significant operational efficiencies. However, a recent study indicates that the merger did not lead to lower consumer prices, as competition between businesses appears to have been reduced. This raises questions about the true benefits of such mergers for consumers in the market.
Don't miss GSK's next move
Get an email the moment GSK makes an acquisition, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
M&A Insights
Based on deal dataFrequently asked
Who acquired Pfizer?
Pfizer was acquired by GSK, based in London. The deal was reported on August 25, 2026. GSK is a global healthcare company engaged in the research, development, and manufacture of pharmaceutical products and vaccines. It focuses on providing innovative healthcare solutions and improving patient outcomes. GSK is publicly traded (GSK) and operates in Manufacturing.
When did GSK acquire Pfizer?
GSK's acquisition of Pfizer was reported on August 25, 2026. In 2019, GSK and Pfizer combined their consumer healthcare businesses, aiming for significant operational efficiencies. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Pfizer do?
Seagen is a biotechnology company focused on developing innovative therapies for cancer treatment. The company specializes in antibody-drug conjugates and has a portfolio of targeted therapies. It is publicly traded (PFE), operating in Biotechnology, and is based in New York.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.